OCAST FY24 Applications: The only OCAST programs to have funding for award in FY2024 (July 1, 2023 – June 30, 2024) are the Oklahoma Applied Research Support (OARS) program and the Intern Partnership program.  The OCAST Health Research, Health Research Fellowship and Plant Science programs will go unfunded in FY2024.  Please note projects supporting industry in the three targeted strategic areas with the greatest probability of maximum return, Biotech/life sciences (including Ag-Tech), aerospace/autonomous systems and defense, and energy diversification are eligible for the OARS program.  The OARS program in FY2024 will not offer proof-of-concept funding. Applications are open August 2^nd.

 

Robert M. Bird Health Sciences Library is providing resources for researchers: 

• HSTalks - The Biomedical & Life Sciences Collection - Animated, online, audio-visual lectures, seminar-style talks and case studies

Henry Stewart Talks Ltd (HSTalks) is a leading provider of specially prepared, animated, online, audio-visual lectures, seminar-style talks and case studies for medical schools, business schools, universities and commercial enterprises in over 60 countries around the world.  Unlimited access 24 hours a day every day of the year.

Editors and lecturers are leading world experts and practitioners, including Nobel Laureates, drawn from academia, research institutes, commerce, industry, the professions and government. The collections are continuously expanded and updated and may be easily embedded in online learning environments such as Moodle and Blackboard.

• JoVE Video Library – Videos demonstrating laboratory Protocols

The complete JoVE video library provides the breadth and depth needed to meet the needs of science students and researchers at all levels.  With videos illustrating basic and advanced concepts and methods, novel experimental research and more, JoVE videos maximize productivity from the classroom to the advanced research laboratory.

• Publication Support Libguide (library guide)

The Publication Support Libguide created by BHS Library faculty outlines publication support that is available through the library.  Topics include selecting a journal for publication, authorship, reporting guidelines, financial assistance, and more.  This and other guides can be found on the library homepage under Guides & Tutorials.

• Northern Light Life Sciences Conference Abstracts

Northern Light’s conference abstracts and posters collection includes content from 1,600 life sciences industry conferences from 2010-present.  This is one of several databases the library purchases on behalf of OUHSC students, faculty, and staff that is available through the Ovid platform.  Over 150 databases and other collections are accessible from the library’s homepage.  On the home page navigate to More Resources using the menu on the left and click on All Databases & Resources A-Z to browse the list.

 

Nature Masterclasses- Professional Development Training for Researchers

Accessing the OUHSC Library Institutional Subscription

Nature Masterclasses provides professional development training for researchers — via online courses and on-demand workshops.  The BHS Library subscribes to an online subscription which is available 24/7, so it’s convenient for the researcher’s schedule.  Periodically, live webinars are offered free to subscribers.

From designing your experiments to advancing your career, Nature Masterclasses offer on-demand courses that cover the whole research cycle, so there is something for everyone, at whatever stage of your career. 

Content includes courses for research design, securing funding, experiment and analyse, write and publish, share and disseminate, develop your career, and work with others.

If you would like to access the OUHSC Nature Masterclasses online (NMO) subscription provided by the library, register using the instructions below.

• Use this link or go to the library's home page and navigate to More Resources à All databases & Resources A-Z, Select the letter N and scroll down to Nature Masterclasses à Click on the link
• You will need to register while on the campus network (or VPN) to create a login. Ignore language to request a quote or buy a subscription, and register using the button in the top right hand corner.
• Once registered you can use your login from anywhere. 
• NOTE:  While on the campus network (or VPN) you will have to login to NMC approximately every 6 months to verify that you are a valid user.  You must have valid OUHSC credentials to continue to use NMC.

 

OK Symposium on Pancreatic Cancer Cachexia
OU Health Stephenson Cancer Center is proud to host the OK Symposium on Pancreatic Cancer Cachexia on August 25-26, 2023 at the Colcord Hotel in Oklahoma City.
The purpose of this symposium is to advance the understanding of the basis of pancreatic cancer cachexia and enhance research collaborations on pancreatic cancer. Pancreatic cancer and cancer cachexia are under-studied areas that have drawn much attention in the last few years. Funded by the Presbyterian Health Foundation and the NCI designated OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, this multidisciplinary symposium will provide a unique opportunity to catalyze interactions among invited speakers and local investigators through sharing ideas, research discoveries, and challenges towards advancing the field of pancreatic cancer cachexia. The meeting will highlight speakers from many premier research institutions in the nation, and local speakers from several institutions within the state. The topics to be covered will feature cutting edge technologies, new animal models and novel discoveries on pancreatic cancer cachexia. Specifically: muscle wasting, adipose loss, cross talk between muscle and adipose and tumor cells, inflammation, metabolism, extracellular vesicles, microRNAs, cytokines, and pancreatic cancer metastasis.

Register: 2023 International Ovarian Cancer Research Conference Registration (qualtrics.com)  

Contact: Emily Hulseberg emily-hulseberg@ouhsc.edu

 

Omics for the Biomedical researcher workshop

This fall we are planning on having a workshop where we will teach biomedical researchers how to perform basic informatics analysis, with a particular focus on single cell RNA sequencing. In this hands-on workshop, we will teach participants how run raw data (in the form of FASTQ files) through Cellranger, upload the data into R, process the data, and generate usable visualizations including UMAPs, Heatmaps, and volcano plots. We will also teach researchers how to perform ligand-receptor and pseudotime analysis.  These analyses will be done using bash, linux, R, and python platforms. This workshop will take place over the course of ~four months and will require the participant to attend one, four-hour session per week (12 sessions total). The course will be held in person at the Samis Center, East Boardroom. No fee will be charged for the workshop. A description of the requirements and applications materials is listed below. We anticipate accepting 10 applicants into the workshop. Applications are due by July 15^th, 2023. Please send application materials to Kurt Zimmerman (kurt-zimmerman@ouhsc.edu).

Please see attached document for more complete information and the schedule of classes.

 

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

• Hoya Surgical Optics is seeking opportunities related to intraocular lens development, preloaded IOL injectors and biocompatibility of hydrophobic lens materials.  Approaches of interest include innovations in optical and mechanical lens design, modification of lens materials, novel injector materials and methods, solutions to lens epithelial cell adhesion, and novel optical equipment. Out of scope: research relating to contact lenses or scleral lenses.    Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/01).
• Biotype, an incubator initiative of VIP, is searching for agri-food biotech innovations ready for early stage spin-out support.  Areas of interest include plant biotechnology towards beneficial agronomic traits, novel active ingredients or sustainable products for crop protection, molecular farming for production of products such as supplements, and technologies to improve health and wellbeing of humans or animals.  Out of scope: opportunities related to IT or robotics and business to consumer products.  Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/01).
• Smart Immune, who has recently developed an innovative bioproduction method for cultivating T cell progenitors, is seeking a CAR construct that enables precise recognition of tumor antigens, in order to develop CAR-T cell therapy for treatment of hematological and/or solid tumor malignancies.  All types of CARs, CAR-T generation methods and mechanisms of action within oncology are of interest.  Out of scope: screening platforms for receptor discovery, CAR constructs designed to target antigens unrelated to oncology, novel CAR-T cell delivery methods/routes of administration. Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/01).
• EuroFarma, a Brazilian pharmaceutical company, is seeking antimicrobial small molecules from natural sources for drugs/therapies.  Of particular interest are small molecules, both natural products and their derivatives, that target gram-negative and ESKAPE pathogens or other pathogens related to antimicrobial resistance.  Approaches that target Candida, Aspergillus fumigatus, Gram positive bacteria and human cytomegalovirus, RSV and rhinovirus will also be considered.  Out of scope are nucleic acids and proteins, and non-molecular approaches such as probiotics or phytotherapeutic medicines. Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/10).

 

NOTE: If the project is selected to move forward with a full application, it will need to be routed through SoonerTrack II.

 

• Notice of Upcoming NIH Early Prediction of Alzheimer's Disease and Alzheimers Disease Related Dementias (AD/ADRD) Open Innovation Challenge
  (NOT-AG-23-040)
• Pre-Application Webinar for Advancing Cancer Control Equity Research through Transformative Solutions RFAs: RFA-CA-23-026 and RFA-CA-23-027
  (NOT-CA-23-076)
• Notice of Pre-Application Webinar for Evaluating Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) and Potential Risk and Protective Factors (RFA-DK-23-009/RFA-DK-23-010)
  (NOT-DK-23-028)
• Notice of Early Expiration and Reissuance of NOT-HL-22-010 "Notice of Special Interest (NOSI): Research on barriers to care and risk of HIV-associated comorbidities among vulnerable population groups"
  (NOT-HL-23-096)
• NIH Announces the Open Period of FY 2024 Helium-3 Requests for Medical Research
  (NOT-HL-23-098)
• Notice of Pre-Application and Technical Assistance Webinar for RFA-MH-23-300 Developing Measures to Advance Access and Quality in Global Mental Health Services (R34 Clinical Trial Not Allowed)
  (NOT-MH-23-355)
• Notice of Technical Assistance Webinar for RFA-MH-24-120, "Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)"
  (NOT-MH-23-360)
• Request for Information (RFI): National Institute of Dental and Craniofacial Research (NIDCR) Strategic Planning of Infrastructure and Resources for Data Science Research and Research Training
  (NOT-DE-23-008)
• Notice of Correction to NOT-CA-23-071: Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials
  (NOT-CA-23-075)
• Notice Regarding the Data Management and Sharing Plan for Applications Submitted RFA-ES-23-004 Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed
  (NOT-ES-23-012)
• Notice of Need to Expire and Reissue RFA-ES-23-004 "Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trial Not Allowed)"
  (NOT-ES-23-013)
• Notice of Participation of the National Eye Institute (NEI) in RFA-HL-23-006, "Stimulating Access to Research in Residency (StARR) (R38 Independent Clinical Trial Not Allowed)"
  (NOT-EY-23-008)
• Notice of Correction to the Instructions for Specific Aims in PAR-23-122 "Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)"
  (NOT-GM-23-023)
• Notice of Clarification of NIH BRAIN Initiative Institutional Letter for RFA-MH-23-330 and RFA-MH-23-331 K99/R00 - BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity
  (NOT-MH-23-345)
• Notice of Early Expiration of PAR-22-248: HIV/AIDS Scholars Using NHP Models Program (K01 Independent Clinical Trial Not Allowed) and PAR-22-252: Early Stage Investigator HIV/AIDS Research Using NHP Models (R21 Clinical Trial Not Allowed)
  (NOT-OD-23-148)
• Notice of Change to Application Instructions for RFA-RM-23-007 "NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)"
  (NOT-RM-23-019)
• Notice of Intent to Publish a Funding Opportunity Announcement for Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional)
  (NOT-LM-23-003)
• Notice of Special Interest: Secondary Analyses of Existing Alcohol Research Data
  (NOT-AA-23-011)
• Notice of Special Interest (NOSI): Advancing Biomedical Research in Pulmonary Non-Tuberculous Mycobacterial (NTM) Infections
  (NOT-AI-23-050)
• Notice of Special Interest (NOSI): Availability of Administrative Supplements for Submission to the ASPIRE (A Specialized Platform for Research Exploration) Collaborative Research Program
  (NOT-TR-23-019

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

• Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
  (PA-23-189)
  Application Receipt Date(s): Due dates vary by awarding IC.
• NEI Translational Research Program for Therapeutics (R61/R33 Clinical Trial Not Allowed)
  (PAR-23-200)
  Application Receipt Date(s): March 16, 2025
• NEI Translational Research Program for Therapeutics (R33 Clinical Trial Not Allowed)
  (PAR-23-205)
  Application Receipt Date(s): March 16, 2025
• Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
  (PAR-23-215)
  Application Receipt Date(s): September 07, 2025
• HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)
  (PAR-23-225)
  Application Receipt Date(s): September 07, 2025
• Data Analysis and Coordination Center for the PsychENCODE Consortium (U24 Clinical Trial Not Allowed)
  (PAR-23-234)
  Application Receipt Date(s): August 24, 2023
• Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
  (PAR-24-023)
  Application Receipt Date(s): Multiple dates, see announcement.
• Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
  (PAR-24-026)
  Application Receipt Date(s): Multiple dates, see announcement.
• Advancing Development of Diagnostics for Congenital and Adult Acquired Syphilis (R21 Clinical Trial Not Allowed)
  (RFA-AI-23-039)
  Application Receipt Date(s): November 02, 2023
• Limited Competition: NIH-DoD-VA Pain Management Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-AT-24-002)
  Application Receipt Date(s): August 31, 2023
• Advancing Cancer Control Equity Research Through Transformative Solutions (U19 Clinical Trial Optional)
  (RFA-CA-23-026)
  Application Receipt Date(s): September 14, 2023
• Advancing Cancer Control Equity Research through Transformative Solutions Coordination Center (U24 Clinical Trial Optional)
  (RFA-CA-23-027)
  Application Receipt Date(s): September 14, 2023
• Youth Violence Prevention Interventions (R01 - Clinical Trial Required)
  (RFA-MD-24-002)
  Application Receipt Date(s): October 02, 2023
• Precision HIV Health: Integrating Data and Implementation Science to Accelerate HIV Prevention and Treatment (R21/R33 Clinical Trial Not Allowed)
  (RFA-MH-24-100)
  Application Receipt Date(s): Not Applicable
• Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
  (RFA-NS-24-009)
  Application Receipt Date(s): September 06, 2023
• Analysis of data in the COVID-19 Neuro Databank-Biobank (R03 - Clinical Trial Not Allowed)
  (RFA-NS-24-025)
  Application Receipt Date(s): November 08, 2023

 

Susan G. Komen: Career Transition Awards (CTA)

Description: Through this NEW grant mechanism, we seek to support outstanding senior postdoctoral and clinical fellows working under the guidance of a mentor to launch their competitive, independent breast cancer research careers.  With these Career Transition Awards (CTA), Komen will continue to support the training and career development of the next generation of leaders, while promoting research that will help us achieve our strategic imperatives and end breast cancer.

The Career Transition Awards provide up to five years of funding in two phases: Phase 1 supports the final years of mentored, postdoctoral training and Phase 2 supports the independent research of the early career, tenure-track investigators. Research projects must be hypothesis-driven, breast cancer-focused studies. They may be considered basic, translational, clinical and/or population science in nature and should align with Komen’s research goals and priorities and mission to save lives from breast cancer.

Letters of Intent Due: July 14, 2023, by 1 p.m. EST

Full Applications Due: September 20, 2023, by 1 p.m. EST

Link to Full Announcement: https://www.komen.org/breast-cancer-research/grants/opportunities/

 

Cystic Fibrosis (CF) Foundation: Newborn Screening Improvement Program Award

Description: Applications are now being accepted for the 2023 Screening Improvement Program (SIP) Award for Optimizing the Diagnosis of Infants. The application deadline is July 10, 2023. Please review the SIP Award Policies and Guidelines for full details on the award and instructions for the application process. For questions, contact Marissa Rollins (mrollins@cff.org).

 

The Chan Zuckerberg Initiative (CZI): Deep Tissue Imaging RFA

Description: The Chan Zuckerberg Initiative (CZI) seeks to support four-year projects to advance the field of deep tissue imaging, which aims to obtain cellular resolution in complex tissue and through skin and bone. To gain a deeper mechanistic understanding of biological systems, CZI’s Imaging program aims to visualize and measure them across biological scales and in their biological context. This RFA seeks to drive development of imaging technology focused on obtaining cellular resolution readouts within complex living organisms. 

Letters of Intent Due: July 11, 2023

Link to Full Announcement: https://chanzuckerberg.com/rfa/deep-tissue-imaging/

 

The Robert Wood Johnson Foundation’s (RWJF): Health Data for Action (Data Access Award)

Description: Access to rich data is a cornerstone of producing timely and objective research. Data can build evidence that leads to a fair and just opportunity for health, for all. 

A new call for proposals offers no-cost access to timely, relevant, inclusive data that inform policy to make healthcare more affordable and equitable. 

Health Data for Action will award successful applicants with access to data sets to support innovative research that answers important research questions and inform health policy. Data include electronic health record and clinical data; claims and encounter data; and transparency in coverage data.

First-time principal investigators will receive funding up to $100,000 per project.

Applications Due: August 18, 2023

Link to Full Announcement: https://www.rwjf.org/en/grants/active-funding-opportunities/2023/health-data-for-action-data-access-award.html?rid=0032S00002ZyzqpQAB&et_cid=2196580

 

HRSA Behavioral Health Workforce Education and Training- Children, Adolescents, and Young Adults (BHWET-CAY) Program for Professionals

Description: The purpose of the BHWET-CAY Program is to increase the supply and distribution of behavioral health providers in rural and underserved communities to address the behavioral health needs of children, adolescents, and young adults (ages 16-25). The BHWET-CAY Program aims to address specific bottlenecks in recruiting and training behavioral health professionals including by providing stipends to support trainees during their clinical/experiential training and by increasing the supply of and training for clinical supervisors overseeing trainees. 

Application deadline: July 14, 2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-131

 

HRSA Maternity Care Nursing Workforce Expansion (MatCare) Program

Description: The purpose of the MatCare Program is to support accredited nurse midwifery programs to train nurse midwives through trainee scholarships, stipends, curriculum enhancement, and community-based training. The program seeks to grow and diversify the maternal and perinatal health nursing workforce through support for education and training in rural and underserved communities. 

Application deadline: July 14, 2023

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-120

 

DoD Duchenne Muscular Dystrophy Research Program (DMDRP)

• Idea Development Award (IDA)
• Translational Research Award (TRA)

Pre-Application (Letter of Intent) deadline: August 2, 2023
Application deadline: August 23, 2022

Link to Full Announcement: https://cdmrp.health.mil/funding/dmdrp